The possibility of what we can discover from the very fundamental research we do on chronic diseases is what makes my work really interesting.
As a child, some of my close family suffered from cancer, so when I started university I became fascinated with the study of tumour immunology. I found it intriguing that people were looking to the immune system to fight off cancer as a new form of treatment.
Now that I’m working at Centenary I’ve been able to do just that. I’m essentially investigating the best strategy for the immune system to stop tumour growth. I look at two cell types, CD4 T cells and B cells, and how these two cells work together to kill tumours once regulatory T cells (T regs) are switched off. T regs are the network managers of our immune system. Continue reading